All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Neoplasms-20870281

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	20870281	C595T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
2	20870281	C632T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
3	20870281	C753T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
4	20870281	C798T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
5	20870281	G599A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
6	20870281	G63D	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
7	20870281	G63S	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
8	20870281	G760A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
9	20870281	G761A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
10	20870281	G819A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
11	20870281	G854A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
12	20870281	G954A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
13	20870281	L8L	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
14	20870281	Q82Q	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
15	20870281	Q97Q	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
16	20870281	R9K	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
17	20870281	S94N	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
18	20870281	T20I	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
19	20870281	T57T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
20	20870281	T744G	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
21	20870281	T75T	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
22	20870281	T803C	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
23	20870281	V77A	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
24	20870281	Y60Y	E7	E7	Uterine Cervical Neoplasms	G R S C L	View
25	20870281	A388C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
26	20870281	A479C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
27	20870281	C307T	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
28	20870281	C66C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
29	20870281	E32Q	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
30	20870281	G203C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
31	20870281	G432A	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
32	20870281	K93N	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
33	20870281	R108K	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
34	20870281	R124R	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
35	20870281	A378C	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
36	20870281	A378G	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
37	20870281	A530G	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
38	20870281	A83A	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
39	20870281	G350T	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
40	20870281	K93G	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
41	20870281	K93Q	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
42	20870281	K93R	E6	E6	Uterine Cervical Neoplasms	G R S C L	View
43	20870281	R143R	E6	E6	Uterine Cervical Neoplasms	G R S C L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.